The voluntary model for states, called GENErating cost Reductions fOr U.S. Medicaid (GENEROUS) allows state Medicaid programs ...

Over 12 million low-income seniors are dual-eligible for Medicare and Medicaid/SNAP. Explore how simultaneous changes to ...

The two-month reprieve extends through January 2026. While some providers are restarting telehealth services, it remains ...

The Centers for Medicare & Medicaid Services (CMS) late last week announced the creation of the GENErating cost Reductions for US (GENEROUS) Medicaid Model, which will utilize most-favored nation ...

Trump announces deal with Eli Lilly, Novo Nordisk to lower cost of GLP-1 weight loss drugs Wegovy, Zepbound. Here's what to ...

The stopgap spending bill signed Nov. 12 by President Donald Trump halts a looming $536 billion Medicare cut and temporarily extends several key health programs, avoiding deeper disruptions from the ...

The Centers for Medicare & Medicaid Services (“CMS”) recently finalized a Medicare payment rule with significant implications for life ...

Trump’s GLP-1 price deal slashes costs and expands selective Medicare coverage—threatening telehealth startups and sparking a ...

The deals are among the most politically significant announcements to date in the Trump administration's efforts to rein in ...

Medicare will cover GLP-1 weight loss drugs for specific patient groups, beginning in mid-2026, under a deal struck with drugmakers.